Clinical Trial Update: Trial to Determine the Maximum Tolerated Dose of Genexol-PM Plus Gemcitabine and Evaluate Efficacy and Safety of Genexol-PM Regimens in Subjects With Advanced Pancreatic Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated Genexol-PM in combination with gemcitabine to determine the maximum tolerated dose and assess preliminary efficacy and safety in patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Genexol-PM (paclitaxel)

Snippet

Sponsor: Samyang Biopharmaceuticals Corporation | Conditions: Pancreatic Cancer | Phase 1 | Status: COMPLETED